Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Laurus Labs Acquisition Worth ₹35.63 Cr

Laurus Labs approved buying 60% of Canada-based CRO Galenvs Sciences for USD 3.75 million (₹35.63 Cr). The deal adds an oligonucleotide R&D arm and North American presence.

Key figures
Value₹35.63 Cr
Source

NSE filing, NSE: LAURUSLABS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Laurus Labs Ltd: key numbers

Share price
₹2,170.00
Market cap
₹1,17,248 Cr
Revenue (annual)
₹6,813 Cr
Net profit (annual)
₹888.8 Cr
P/E (TTM)
107.2×Sector 46.1×
Promoter holding
27.47%+0.00% QoQ
FII holding
30.84%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Laurus Labs Ltd

All →
14:55 IST NSE
Financial Results

Laurus Labs Q2 FY27 Results: Net Profit ₹436.2 Cr, Up 124.3% YoY

Laurus Labs Ltd reported revenue from operations of ₹2,206 Cr (+33.4% YoY) and net profit of ₹436.2 Cr (+124.3% YoY) for Q2 FY27.

Key figure
Net profit ₹436.2 Cr · +124.3% YoY

Other acquisition announcements

All →